Submission 1 definition

Submission 1. May 2022 Depending upon the project stage (baseline or remeasurement) ACOs will submit either: 1. QI proposals that describe planned activities and data collection plans for initial implementation; or 2. Project Progress report detailing changes made resulting from feedback or lessons learned in the previous cycle. Plans will provide updates on the current year’s interventions and identify challenges for discussion and problem-solving with EOHHS or its designee. • Project Implementation: May – September 2022 ACOs implement Mid-year interventions and collect data on short-term indicators • Submission 2: September 2022 ACOs submit annual reports describing current interventions, report on short-term indicators, performance data as applicable, and assess results including success and challenges. Reports will also include plans for modifications in the final quarter and plans to continue work in future cycles. Figure 1: ACO QI Goals 2, CY22 Timeline: CY22 PIP Milestones PROJECT START SCORING WORKSHEETS PROVIDED TO PLANS SUBMISSION 2 (YEAR END REPORT) PROJECT END SUBMISSION 1 (PLANNING/PROGRESS REPORT)
Sample 1Sample 2Sample 3

Examples of Submission 1 in a sentence

  • Report Submission 1) The U.S. Department of Labor (DOL) Employment and Training Administration (ETA) requires all grant recipients to submit the ETA-9130 Financial Report electronically through an on-line reporting system.

  • Accounted for by other state reconciliation processes.Students who graduated during the prior school year, including summer graduates up through August 31st are reported in Submission 1.

  • Mr Wright, Clerk of the House of Representatives, Submission 1, p.

  • Students enrolled in all other grade levels should be reported with a blank.For Submission 1: report grade level reading status based on the Beginning of Year assessment results.For Submission 3: report grade level reading status based on the latest assessment results available for the student.

  • Submission 1 of 2 of the College Annual Equity Update is due to the Florida Department of Education, Division of Florida Colleges by April 30, 2019.

  • The acts or proceedings of meetings of Members shall be adopted by resolution and shall be entered in a minute book and confirmed at the next meeting of Members.

  • Bidders to keep themselves updated with all such information.ApplicablexiiiTender SubmissionTender shall be submitted by either of following two modes (Hard copy submission/E-mail Submission): 1.

  • Consultation Submissions: Submission 1 One respondent requested further clarification of the frequency modes including diagrams in order to understand how they relate, interact and what performance is proposed.

  • AS-OF-STATUS-CODEs A through G are used in Submission 1 and only in Submission 1 and indicate student enrollment status within the school-start window and on the PEIMS fall as-of date in the current year.

  • If more than one of these need to be changed, then TEA will have to make the corrections to the PID for you.Districts must take appropriate measures to ensure that prior year students who are "no shows" in the current year are not "rolled over" in the student system and reported as enrolled students in the district's PEIMS Submission 1.

Related to Submission 1

  • Submission Location means the submission location identified as such in the Summary of Key Information.

  • Submission Date means the date on which You Submit a Contribution to Us.

  • Submission Deadline means 1:00 P.M., New York City time, on any Auction Date or such other time on any Auction Date as may be specified by the Auction Agent from time to time as the time by which each Broker-Dealer must submit to the Auction Agent in writing all Orders obtained by it for the Auction to be conducted on such Auction Date.

  • Application Review Start Date means the later date of either the date on which the District issues its written notice that the Applicant has submitted a completed Application or the date on which the Comptroller issues its written notice that the Applicant has submitted a completed Application and as further identified in Section 2.3.A of this Agreement.

  • Time for Completion means the time for completing the Works as stated in the Contract Data (or as extended under Sub-Clause 7.3), calculated from the Commencement Date.

  • Bid Submission Date means the last date by which the City will accept Bids for an Invitation For Bid.

  • Renewal Application means a document used to collect pertinent data for renewal of permits

  • Pre-commissioning means the testing, checking, and any other required activity that may be specified in the Technical Requirements that are to be carried out by the Supplier in preparation for Commissioning of the System as provided in GCC Clause 26 (Installation).

  • Commissioning Tests means all of the procedures and tests which, in accordance with the Reasonable and Prudent Standard, and in compliance with industry guidelines, practices and standards, are:

  • Bid Submission Requirement means a task a Prospective Contractor must complete when submitting a bid response. These requirements will be distinguished by using the term “shall” or “must” in the requirement.

  • Phase 2 means the second implementation phase of this section, beginning June 1, 2022 and continuing thereafter.

  • Subject of a Clinical Trial means the health care service, item, or drug that is being evaluated in the Approved Clinical Trial and that is not a Routine Patient Cost.

  • Phase 1 means the first implementation phase of this section, beginning June 1, 2018 and ending May 31, 2022.

  • Tests after Completion means the tests (if any) which are specified in the Contract and which are carried out in accordance with the Specification after the Works or a Section (as the case may be) are taken over by the Procuring Entity.

  • Expedited review means an examination, in accordance with

  • Approval Application means a BLA, NDA or similar application or submission for a Product filed with a Regulatory Authority in a country or group of countries to obtain marketing approval for a biological or pharmaceutical product in that country or group of countries.

  • Planning Submission or “CAPS” or “Community Accountability Planning Submission” means the HSP Board approved planning document submitted by the HSP to the LHIN. The form, content and scheduling of the Planning Submission will be identified by the LHIN;

  • Commissioning means the process for determining the need for and for obtaining the supply of healthcare and related services by the Trust within available resources.

  • Phase 3 means the period commencing on the day after the Phase 2 implementation date and ending on the Phase 3 implementation date (as defined below).

  • Commissioning test means tests applied to the Generating Facility, after completion of the construction of the Generating Facility, in order to verify that the Generating Facility may be released for Operation.

  • Clinical Trial means a Phase I Clinical Trial, Phase II Clinical Trial or Phase III Clinical Trial, or any post-approval human clinical trial, as applicable.

  • Training Plan means the plan that outlines what training and assessment will be conducted off-the-job and what will be conducted on-the-job and how the Registered Training Organisation will assist in ensuring the integrity of both aspects of the training and assessment process.

  • Clinical Trials means a controlled study in humans of the safety or efficacy of a Product, and includes, without limitation, such clinical trials as are designed to support expanded labeling or to satisfy the requirements of an Agency in connection with any Product Approval and any other human study used in research and Development of a Product.

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.

  • Phase 1 Clinical Trial means a Clinical Trial of a Product on sufficient numbers of normal volunteers and/or patients that is designed to establish that such Product is safe for its intended use and to support its continued testing in Phase 2 Clinical Trials. For purposes of this Agreement, ‘initiation’ of a Phase 1 Clinical Trial for a Product means the first dosing of such Product in a human subject in a Phase 1 Clinical Trial.

  • Drug Approval Application means an application for Regulatory Approval required before commercial sale or use of a Product as a drug in a regulatory jurisdiction.